Research Portal

U.S.-listed market research with live data and structured thesis notes.

Side-by-side research view

Compare names across metrics and research quality

Use up to 4 U.S.-listed names from this dashboard to compare valuation, growth, cash flow, balance-sheet strength, and the curated investment case in one place.

4 stocks in current compare
4 max names side by side
24 shared metrics lined up

Build a compare set

Enter comma-separated tickers from the dashboard universe. Duplicate tickers are ignored automatically.

Clear
Compute Stack AI Platforms Power Buildout Robotics
TSLA Robotics

Tesla

Autonomy + embodied AI platform

Detail page

Tesla is one of the clearest public ways to express a view on real-world AI through autonomy, robotics, and edge inference.

Price $367.96
1D change -3.24%
Market cap $1.38T
Sector Consumer Cyclical
SYM Robotics

Symbotic

Warehouse robotics platform

Detail page

Symbotic is one of the cleanest public ways to own large-scale warehouse robotics and AI-driven logistics automation.

Price $50.12
1D change -2.26%
Market cap $30.19B
Sector Industrials
TER Robotics

Teradyne

Collaborative + mobile robotics

Detail page

Teradyne gives you exposure to collaborative robots and autonomous mobile robots through Universal Robots and MiR.

Price $290.83
1D change -3.83%
Market cap $45.53B
Sector Technology
ISRG Robotics

Intuitive Surgical

Surgical robotics leader

Detail page

Intuitive is the dominant public surgical robotics franchise and belongs in any serious robotics basket.

Price $477.97
1D change -0.41%
Market cap $169.76B
Sector Healthcare

Shared metric table

Live market metrics plus reported quarterly revenue and profit QoQ rows.

Green and red only apply where direction is meaningful. Quarterly revenue and profit cells inherit the sign of the reported QoQ change, which can swing sharply when the prior quarter included a one-time item.

Metric TSLA SYM TER ISRG
Price $367.96 $50.12 $290.83 $477.97
1D Change -3.24% -2.26% -3.83% -0.41%
Market Cap $1.38T $30.19B $45.53B $169.76B
Enterprise Value $1.35T $4.81B $45.49B $164.10B
Trailing P/E 343.9 — 84.1 60.6
Forward P/E 130.9 66.7 35.4 41.8
Price / Sales 14.6 12.6 14.3 16.9
EV / Revenue 14.3 2.0 14.3 16.3
Revenue Growth -3.1% 29.4% 43.9% 18.8%
Earnings Growth -60.6% — 81.4% 16.6%
Gross Margin 18.0% 19.8% 58.2% 66.0%
Operating Margin 4.7% 1.9% 30.3% 30.2%
Net Margin 4.0% -0.5% 17.4% 28.4%
ROE 4.9% -9.0% 19.7% 16.7%
Free Cash Flow $3.73B $640.6M $270.6M $2.27B
FCF Margin 3.9% 26.8% 8.5% 22.6%
Debt / Equity 0.18x 3.13x 0.10x 0.95x
Current Ratio 2.16x 1.38x 1.75x 4.88x
Dividend Yield — — 18.00% —
Next Earnings Apr 21, 2026 May 04, 2026 Apr 29, 2026 Apr 21, 2026
Quarterly Revenue $24.90B $630.0M $1.08B $2.87B
Revenue QoQ -11.4% +1.9% +40.8% +14.4%
Quarterly Net Income $840.0M $2.6M $257.2M $794.8M
Net Income QoQ -38.8% +171.8% +115.1% +12.8%

TSLA thesis lens

Autonomy + embodied AI platform

Why it could benefit

  • Tesla is one of the clearest public ways to express a view on real-world AI through autonomy, robotics, and edge inference.
  • If Full Self-Driving improves materially, software and fleet economics can matter more than the market's usual auto framing.
  • Optimus adds long-duration upside tied to embodied AI rather than just electric vehicles.

Moat / edge

  • Large real-world driving dataset and vertically integrated vehicle stack.
  • Tight integration across hardware, software, training infrastructure, and deployment.
  • A successful autonomy platform could create a much broader valuation framework than traditional autos.

What to watch

  • FSD progress, monetization, and regulatory acceptance.
  • Vehicle gross margins excluding one-time factors and incentives.
  • Whether Optimus and AI services become investable contributors rather than narrative optionality.

Key risks

  • Execution and valuation both depend heavily on autonomy actually delivering.
  • Auto cyclicality and pricing pressure can still dominate results if the AI thesis stalls.

SYM thesis lens

Warehouse robotics platform

Why it could benefit

  • Symbotic is one of the cleanest public ways to own large-scale warehouse robotics and AI-driven logistics automation.
  • Its systems sit directly in the path of retailer and distributor pressure to move goods faster with less labor.
  • The company also gives the dashboard a more explicit physical-AI and supply-chain-robotics angle.

Moat / edge

  • Deep specialization in high-throughput warehouse automation.
  • Large customer relationships and long deployment cycles once a system is chosen.
  • A full-stack hardware-plus-software approach that is hard to swap out quickly.

What to watch

  • Walmart and other major customer program ramps.
  • Backlog conversion and project gross margins.
  • How successfully Symbotic expands into adjacent fulfillment workflows.

Key risks

  • A concentrated customer base can make results lumpy.
  • Complex deployments can move slower than headline demand suggests.

TER thesis lens

Collaborative + mobile robotics

Why it could benefit

  • Teradyne gives you exposure to collaborative robots and autonomous mobile robots through Universal Robots and MiR.
  • It is one of the more established public ways to own industrial robotics rather than a tiny speculative name.
  • As factories automate more tasks end to end, Teradyne can benefit from both robotics adoption and test-equipment cash flows.

Moat / edge

  • Strong robotics assets in Universal Robots and MiR.
  • Established industrial relationships and a global support footprint.
  • A broader company base that can fund robotics investment over time.

What to watch

  • Robotics segment growth versus the core test business.
  • New product cycles in cobots and AMRs.
  • Evidence that AI is improving robotic use cases and ROI for customers.

Key risks

  • The legacy test business can dominate stock behavior in some periods.
  • Industrial automation demand can soften with the broader factory cycle.

ISRG thesis lens

Surgical robotics leader

Why it could benefit

  • Intuitive is the dominant public surgical robotics franchise and belongs in any serious robotics basket.
  • Its installed base, procedure growth, and recurring instruments model create a stronger moat than most robotics names.
  • This adds a high-quality medical robotics angle that is less tied to data-center spending or industrial cycles.

Moat / edge

  • Large installed base and deep surgeon training ecosystem.
  • Recurring revenue from instruments, accessories, and service.
  • Years of lead time and brand strength in robotic-assisted surgery.

What to watch

  • Procedure growth and system placements.
  • Adoption of newer da Vinci platforms and adjacent products.
  • Gross-margin resilience as the business scales.

Key risks

  • Premium valuation can leave less room for execution misses.
  • Hospital capital-spending cycles still matter.